Inhibrx Biosciences, Inc.INBXNASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank22
Studio
Year-over-Year Change

Pre-tax earnings

Latest
$-140.05M
↓ 258% vs avg
Percentile
P22
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$88.90M
Historical baseline
PeriodValueYoY Change
TTM$-140.05M-108.3%
2024$1.69B+804.0%
2023$-239.72M-65.1%
2022$-145.22M-77.6%
2021$-81.77M-8.1%
2020$-75.63M-49.8%
2019$-50.50M-63.3%
2018$-30.93M-41.7%
2017$-21.83M-69.4%
2016$-12.88M-